Previous close | 91.88 |
Open | 91.89 |
Bid | 90.33 x 0 |
Ask | 92.17 x 0 |
Day's range | 91.12 - 92.46 |
52-week range | 80.62 - 104.70 |
Volume | |
Avg. volume | 1,662,297 |
Market cap | 120.359B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | 13.32 |
EPS (TTM) | 6.85 |
Earnings date | 25 July 2024 |
Forward dividend & yield | 3.56 (3.60%) |
Ex-dividend date | 30 May 2023 |
1y target est | N/A |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Q1 2024 Kymera Therapeutics Inc Earnings Call
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.